CBD during menopause

What are the typical symptoms of menopause, and what causes them?

Menopause (climacteric) refers to the natural transitional phase in a woman's life during which ovarian hormone production - particularly estrogen and progesterone - gradually declines. This hormonal change leads to profound physiological and psychological changes, which can manifest as a wide range of menopausal symptoms.

Those who would like to learn more comprehensively about the physical changes, symptoms, and various phases of menopause can find an independent knowledge platform at MeNotPause, offering well-founded information about perimenopause and menopause.

Hormonal foundations

• During perimenopause (the years before the final menstrual period), estrogen levels begin to fluctuate irregularly, often accompanied by progesterone deficiency.
  

• With the onset of postmenopause, estrogen levels decline permanently, affecting numerous bodily systems: the nervous system, vascular tone, sleep regulation, mucous membranes, skin, and bone metabolism.

Typical symptoms at a glance

Frequency and progression

• Up to 80% of women report vasomotor symptoms such as hot flashes.
  

• The duration of symptoms can vary greatly: from a few months to more than ten years.
  

• Symptoms are particularly burdensome when they affect several areas of life at the same time - e.g. sleep quality, work performance, and relationships.

Menopausal symptoms arise from a complex interplay of hormonal dysregulation, neurological adaptation processes, and psychosocial factors. Since hormone replacement therapy is not suitable for all women, non-hormonal approaches - such as CBD-containing products like CBD-containing products such as CANNEFF® VAG SUP - are becoming increasingly important.

What role does the endocannabinoid system play during menopause?

The endocannabinoid system (ECS) is a central, endogenous regulatory system that is involved in many physiological processes - including thermoregulation, mood, sleep, pain perception, inflammatory responses, and hormonal balance. During menopause, when estrogen levels decline sharply, functional changes in the ECS occur that may play a key role in the development of typical menopausal symptoms.

Structure and function of the endocannabinoid system

The ECS consists of three main components:

Hormonal regulation of the ECS during menopause

• Estrogens directly modulate the ECS: They increase anandamide production and CB1 receptor density.

• During menopause, estrogen levels decline, leading to a reduction in anandamide and CB1 expression.

• This can contribute to hypersensitivity of the thermoregulatory center, impaired stress processing, and an increase in inflammatory processes.

Relevance of the ECS to menopausal symptoms

Importance for therapy during menopause

• Weakened ECS activity resulting from the decline in estrogen can intensify typical symptoms such as hot flashes, irritability, or sleep disturbances.
  

• CBD (cannabidiol) does not act directly as an agonist at CB1/CB2, but modulates the ECS through:

• Inhibition of anandamide breakdown (FAAH inhibition

• TRPV1 modulation, relevant to heat and pain perception

• 5-HT1A activation, mood- and sleep-promoting

The endocannabinoid system is closely linked to hormonal balance and the central regulation of menopausal symptoms. During menopause, the decline in endogenous cannabinoid activity contributes to the intensification of vasomotor, emotional, and physical symptoms. Products such as CANNEFF® VAG SUP, which specifically influence the ECS, may provide an effective, hormone-free therapeutic option in this context.

How does CBD work in the body - and why is it interesting for women going through menopause?

Cannabidiol (CBD) is a non-psychoactive compound in the cannabis plant that has a wide range of biological effects - particularly in the areas of nervous, hormonal, and immune regulation. For women going through menopause, CBD is therefore medically interesting because it specifically influences those systems destabilized by the decline in estrogen: the endocannabinoid system (ECS), serotonin levels, and inflammation- and pain-related signaling pathways.

Mechanisms of action of CBD

Why is this relevant for women going through menopause?

Relief from hot flashes

CBD acts via the ECS and TRPV1 on the thermoregulatory center in the hypothalamus, which becomes hypersensitive due to the drop in estrogen. Studies such as the one by Sui et al. (2022) and the CANNEFF® study (2024) demonstrate a significant reduction in vasomotor symptoms.

Stabilization of mood and sleep

CBD is non-psychotropic but has demonstrated anxiolytic, antidepressant, and sleep-promoting properties. This is particularly relevant because many women during menopause suffer from irritability, restlessness, or sleep disorders.

Anti-inflammatory and pain relief

CBD inhibits inflammatory processes and modulates the immune response. This can alleviate joint discomfort, feelings of tension, and mucosal irritation - typical symptoms of hormonal deficiency.

Safe and hormone-free

CBD does not affect the body hormonally, has no addictive potential, and does not produce THC-like psychotropic effects. In particular, CANNEFF® VAG SUP, a medically tested vaginal suppository with CBD and hyaluronic acid, showed no relevant side effects in clinical studies, while having a positive effect on menopausal symptoms.

CBD exerts its effects through several synergistic pathways that are closely linked to the typical symptoms of menopause. By modulating the ECS, stabilizing serotonin receptors, and exerting anti-inflammatory effects, CBD - particularly in tested dosage forms such as CANNEFF® VAG SUP - is a safe, hormone-free, holistic option to support women during menopause.

Which scientific studies investigate CBD for menopausal symptoms?

What distinguishes medical CBD products such as CANNEFF® from over-the-counter CBD products?

The market for CBD products has grown significantly in recent years - from oils, capsules, and cosmetics to applications close to medicinal products. However, it is often difficult for consumers to tell which products have undergone medical testing and which are sold merely as food supplements or lifestyle products. A key difference exists between over-the-counter CBD products and medically approved products such as CANNEFF® VAG SUP, a Class IIa vaginal medical device specifically developed for women during menopause.

CANNEFF® VAG SUP vs. other CBD products

Benefits of CANNEFF® VAG SUP

• Targeted effects in the urogenital area, ideal for hot flashes, vaginal dryness, irritability, and pain during sexual intercourse.

• Combined with hyaluronic acid for mucosal care and anti-inflammatory effects in cases of vaginal dryness or injuries in the intimate area.
  

• Clinically proven efficacy (e.g., reduction of the Menopause Rating Scale).
  

• No psychotropic effects, no hormonal burden, a safe alternative to HRT.
  

• Patented pharmaceutical formulation - not comparable to DIY CBD suppositories. 

What role can CBD play as part of a holistic therapeutic approach?

CBD (cannabidiol) is becoming increasingly important as a complementary measure in the holistic treatment of menopause. This is not about isolated use, but about integrating it into a multimodal therapy concept that takes physical, emotional, and hormonal changes into account. CBD offers a well-tolerated, non-hormonal module that can be combined with other therapeutic measures, particularly for women who do not want or cannot tolerate hormone replacement therapy.

CBD as an integrative component in menopause therapy